Deciphering the Threat: Nitazene Arrives Amidst a Ongoing Canadian Opioid Crisis
Tackling a Continued Epidemic
While the opioid crisis in Canada has attracted significant attention and intervention from law enforcement, healthcare institutions and government bodies at various levels, a disturbing development has surfaced in Newfoundland and Labrador, injecting an added degree of complexity and urgency into the national struggle against opioid addiction. According to an report by the Canadian Broadcasting Corporation (CBC), Nitazene – a new synthetic opioid more potent than fentanyl – has arrived on the local drug scene and has already claimed a number of lives.
What is Nitazene?
Nitazene belongs to a category of synthetic opioids similar to fentanyl. Though it is not a new drug, its use as a recreational substance is unprecedented. According to the CBC report, Nitazene is 10-20 times more potent than morphine, and significantly more powerful than fentanyl. Having claimed at least four lives in Canada thus far, the appearance of Nitazene further fuels an already severe opioid crisis.
The Impact of Nitazene on Our Communities
The emergence of Nitazene introduces a new dimension to the opioid crisis within the spectrum of addiction, crime, homelessness, and public health. Here are some key effects;
- Increased fatal overdoses: Nitazene’s high potency drastically raises the risk of fatal overdose. Its arrival in the market, where users may not be aware of its risks, introduces a deadly dynamic to the crisis.
- Impact on crime: Like other opioids, Nitazene may fuel criminal activities associated with drug trafficking, sale and use. This has costs for law enforcement, public safety and community wellbeing.
- Exacerbating homelessness: The opioid crisis has been linked to rising homelessness, as addiction often results in the loss of employment and housing. Nitazene’s advent will likely perpetuate this trend.
- Public health burden: Nitazene and similar opioids place a significant strain on the health care system due to overdose treatments and long-term medical care for those living with addiction.
Combatting Nitazene in the Midst of the Opioid Crisis
In light of Nitazene’s arrival, there is a growing consensus that measures combating the opioid crisis must be intensified and expanded. Here are some efforts being implemented;
Emerging Concern: the Opioid Class Action Lawsuit
An emerging focus in the fight against the opioid crisis is the proposed opioid class action lawsuit against pharmaceutical companies. This suit maintains that these companies should be held accountable for their part in creating and deepening the opioid crisis. As Nitazene enters the scene, it raises further questions about how such legal actions can influence the current situation, and what type of precedence they might set for managing future crises.
Closing Thoughts
The appearance of Nitazene in the already complex web of opioid crisis in Canada is a potent reminder that the journey to overcome this epidemic is far from over. The critical need for augmented and multi-pronged response from government, law enforcement, healthcare, and community organizations is unarguable. There is also a concurrent need to identify and address the socio-economic factors that exacerbate opioid use. As we navigate this crisis, it is clear that everyone has a role to play – professionals, policymakers, and citizens alike.